Secondary genetic factors in cystic fibrosis lung disease

被引:7
|
作者
Mahadeva, R [1 ]
Lomas, DA [1 ]
机构
[1] Univ Cambridge, Wellcome Trust Ctr Mol Mechanisms Dis, Inst Med Res, Dept Med,Resp Med Unit, Cambridge CB2 2XY, England
关键词
D O I
10.1136/thorax.55.6.446
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:446 / 446
页数:1
相关论文
共 50 条
  • [31] Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis
    Hull, J
    Thomson, AH
    THORAX, 1998, 53 (12) : 1018 - 1021
  • [32] Quantification of the Relative Contribution of Environmental and Genetic Factors to Variation in Cystic Fibrosis Lung Function
    Collaco, J. Michael
    Blackman, Scott M.
    McGready, John
    Naughton, Kathleen M.
    Cutting, Garry R.
    JOURNAL OF PEDIATRICS, 2010, 157 (05): : 802 - U149
  • [33] Tissue Repair In Cystic Fibrosis Lung Disease
    Maharaj, S. S.
    Baroke, E.
    Duan, F.
    Freitag, A.
    Welte, T.
    Gauldie, J.
    Kolb, M. R. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [34] Clinical presentation of lung disease in cystic fibrosis
    Stahl, Mirjam
    RADIOLOGE, 2020, 60 (09): : 774 - 780
  • [35] Cystic fibrosis lung disease: Current perspectives
    Jung, Jin-A
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2020, 8 (01): : 3 - 8
  • [36] Antioxidant supplementation for lung disease in cystic fibrosis
    Ciofu, Oana
    Smith, Sherie
    Lykkesfeldt, Jens
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (10):
  • [37] Role of corticosteroids in cystic fibrosis lung disease
    BalfourLynn, IM
    Dinwiddie, R
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1996, 89 : 8 - 13
  • [38] Update on pathogenesis of cystic fibrosis lung disease
    Donaldson, SH
    Boucher, RC
    CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (06) : 486 - 491
  • [39] Emerging therapies for cystic fibrosis lung disease
    Grasemann, Hartmut
    Ratjen, Felix
    EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (04) : 653 - 659
  • [40] An overview of the pathogenesis of cystic fibrosis lung disease
    Boucher, RC
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (11) : 1359 - 1371